Amylin sues Lilly over Boehringer deal; GSK agrees to disclose UNICEF prices;

@FiercePharma: Google near $500M settlement in pharmacy probe. News | Follow @FiercePharma

> Amylin Pharmaceuticals sued its longtime diabetes-drug partner Eli Lilly, saying the larger drugmaker breached their alliance by teaming up with Boehringer Ingelheim on a rival product. Report

> GlaxoSmithKline is now working with UNICEF to enable retrospective publication of the prices it charges the health program, as well as disclosure of future prices. Item

> Alexion Pharmaceutical is expanding its manufacturing plant in Rhode Island, a move expected to add 35 percent more jobs to its current employment of 125 there. News

> Biogen Idec said Australian regulators approved marketing of its multiple sclerosis drug Fampyra. Story

> AstraZeneca purchased for cancellation 334,454 ordinary shares at a price of 3199 pence per share. Article

> Merck South Africa, a subsidiary of Germany's Merck KGaA, has sold its manufacturing to a local private equity firm as part of its ongoing plan to streamline production at facilities around the world. Report

> South Africa's Aspen Pharmacare is working with the Johannesburg-area health department to resolve delays of several months of payments for its supply of AIDS drugs. Item

> U.K. Prime Minister David Cameron will say he is pressing ahead with an overhaul of the state-run National Health Service, rebutting political criticism and attacks from the medical profession. Article

> Dr. Reddy's Laboratories is looking to acquire medicine brands in Russia, CFO Umang Vohra said. Report

> The UK's pharma industry association the ABPI and its biotech equivalent the BIA are jointly relocating to new London offices. Report

> Investors in Alexion Pharmaceuticals approved a 2-for-1 stock split, taking the number of shares to 290 million. Story

Biotech News

 @FierceBiotech: iPierian fires top execs, shifts focus. News | Follow @FierceBiotech

 @JohnCFierce: Bloomberg's Langreth covers the growing number of cancer drugs in the pipeline which rely on epigenetics. Story Follow @JohnCFierce

> Analysis: Big Pharma is backing out of more biotech deals. Article 

> Novartis delivers promising Ph3 data for combo COPD treatment. Item 

> Sanofi forges $663M MS antibody development pact with Glenmark. Report 

> PacBio's Schadt leading $100M effort at Mt. Sinai. News 

> Metabolon plots fast growth as biomarker biz booms. Item 

Biotech IT News

> PerkinElmer acquires Labtronics, buyouts pile up. News 

> Scientists mount computer-aided attack on H1N1 flu virus. Report 

> Sequencing DNA is cheap, analysis not so much. Item

> My visit to Nimbus, Bill Gates' bet on virtual drug discovery. Article 

Medical Device News

> Neuronetics completes Series E, raises $30M. Story 

> Stryker to buy Orthovita for $304M. Report 

> Report: EU needs to do more to ensure device safety. Article 

> Varian Medical grabs $15M stake and buyout option from Augmenix. News 

> Harmac to create 100 jobs in Ireland. Item

> Sorensen named head of Siemens Healthcare in U.S., Canada. Article 

And Finally... Scientists have for the first time confirmed a specific genetic link to depression, according to new evidence published in the American Journal of Psychiatry. Report